- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02997930
fMRI Connectivity in Fracture Hip Patients
August 9, 2019 updated by: University of Florida
Functional Connectivity (With fMRI) as an Objective Measure of Postoperative Cognitive Function in Elderly Fracture Hip Patients
The long-term goal of this study is to evaluate cognitive function preoperatively and develop techniques of intervention in the perioperative period which would optimize brain function and functional recovery following surgery.
Study Overview
Status
Completed
Detailed Description
In this protocol, subjects who are anticipated to be operated for hip fracture will be studied after surgery.
Brief cognitive exam will be done followed by fMRI of connectivity and diffusion tensor imaging (DTI).
Connectivity (neuronal changes) and DTI (Anisotropy and mean diffusivity) data will be compared with age matched controls and correlated with subjective measures of cognition.
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 99 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 65 years and older
- Patients who have fracture hip and are anticipated to have surgery
Exclusion Criteria:
- Patients who have contraindications for MRI like pacemaker, automatic implanted cardiac defibrillator (AICD), implanted infusion pumps etc.
- Patients who are claustrophobic
- Patients with severe cognitive impairment (who may not be able to cooperate during the cognitive exam and fMRI)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Elderly Hip Fracture
Postoperative assess cognitive function in elderly subjects after fracture hip surgery.
Measure function connectivity and DTI (diffusion tensor imaging) via: fMRI.
Subjective measures will include: Montreal Cognitive Assessment (MoCA), Digital Clock Drawing Test Command and Copy, Wide Range Achievement Test reading subtest, Hopkins Verbal Learning Test (HVLT), General Depression Scale (GDS)
|
fMRI for measuring function connectivity and DTI will be done between day 2 to day 5.
A measure of general cognition
A measure of current cognition using digital pen technology
A measure of premorbid intellectual estimate
A measure of declarative memory
A measure of the of presence of depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes between baseline and follow up visits as assessed by fMRI
Time Frame: Change from baseline up to 90 days
|
fMRI for measuring function connectivity and DTI
|
Change from baseline up to 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes between baseline and follow up visits as assessed by MoCA
Time Frame: Change from baseline up to 90 days
|
A measure of general cognition
|
Change from baseline up to 90 days
|
Changes between baseline and follow up visits as assessed by Digital Clock Drawing Test Command and Copy
Time Frame: Change from baseline up to 90 days
|
a measure of current cognition using digital pen technology
|
Change from baseline up to 90 days
|
Changes between baseline and follow up visits as assessed by Wide Range Achievement Test reading subtest
Time Frame: Change from baseline up to 90 days
|
A measure of premorbid intellectual estimate
|
Change from baseline up to 90 days
|
Changes between baseline and follow up visits as assessed by HVLT
Time Frame: Change from baseline up to 90 days
|
A measure of declarative memory
|
Change from baseline up to 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ramachandran Ramani, MD, University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 29, 2017
Primary Completion (Actual)
May 6, 2019
Study Completion (Actual)
May 6, 2019
Study Registration Dates
First Submitted
December 16, 2016
First Submitted That Met QC Criteria
December 16, 2016
First Posted (Estimate)
December 20, 2016
Study Record Updates
Last Update Posted (Actual)
August 12, 2019
Last Update Submitted That Met QC Criteria
August 9, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201601806
- OCR18886 (Other Identifier: University of Florida)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Delirium
-
Qin ZhangNational Natural Science Foundation of ChinaRecruiting
-
Qin ZhangNational Natural Science Foundation of ChinaRecruitingDelirium, PostoperativeChina
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyRecruitingPostoperative Delirium (POD)Switzerland
-
Konya City HospitalCompletedPREOPERATIVE SLEEP QUALITY ON POSTOPERATIVE DELIRIUMTurkey
-
University of VirginiaNational Institutes of Health (NIH); National Institute on Aging (NIA)RecruitingIdentify Postoperative Delirium Using Exhaled Gas PatternsUnited States
-
University Hospital, GhentCompletedPostoperative Pain | Postoperative DeliriumBelgium
-
Menoufia UniversityCompleted
-
Marmara UniversityActive, not recruitingPostoperative Delirium | Postoperative Nausea | Postoperative VomitingTurkey
-
Chinese PLA General HospitalBeijing Tiantan HospitalRecruiting
-
Charite University, Berlin, GermanyBARMERRecruitingDelirium in Old AgeGermany
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States